bioAffinity Technologies, Inc. (BIAF)
USD 1.04
(1.96%)
USD 1.04
(1.96%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -7.93 Million USD | 2.66% |
| 2022 | -8.15 Million USD | -28.89% |
| 2021 | -6.32 Million USD | 12.96% |
| 2020 | -7.26 Million USD | -119.77% |
| 2019 | -3.3 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.11 Million USD | -7.57% |
| 2024 Q1 | -1.96 Million USD | 17.33% |
| 2023 Q2 | -1.74 Million USD | -13.53% |
| 2023 FY | -7.93 Million USD | 2.66% |
| 2023 Q4 | -2.37 Million USD | -3.59% |
| 2023 Q3 | -2.29 Million USD | -31.65% |
| 2023 Q1 | -1.53 Million USD | 8.59% |
| 2022 Q2 | -487.31 Thousand USD | 66.89% |
| 2022 Q1 | -1.47 Million USD | 73.6% |
| 2022 FY | -8.15 Million USD | -28.89% |
| 2022 Q4 | -1.67 Million USD | 65.92% |
| 2022 Q3 | -4.91 Million USD | -909.5% |
| 2021 Q3 | -1.51 Million USD | -202.26% |
| 2021 FY | -6.32 Million USD | 12.96% |
| 2021 Q4 | -5.57 Million USD | -268.4% |
| 2021 Q1 | -716.17 Thousand USD | 66.48% |
| 2021 Q2 | 1.48 Million USD | 306.71% |
| 2020 FY | -7.26 Million USD | -119.77% |
| 2020 Q4 | -2.13 Million USD | 0.0% |
| 2019 FY | -3.3 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -232.49 Million USD | 96.586% |
| Prenetics Global Limited | -62.72 Million USD | 87.346% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -412.727% |
| CareDx, Inc | -190.28 Million USD | 95.829% |
| Exact Sciences Corporation | -204.14 Million USD | 96.112% |
| Exagen Inc. | -23.68 Million USD | 66.495% |
| Inotiv, Inc. | -105.14 Million USD | 92.451% |
| Guardant Health, Inc. | -479.44 Million USD | 98.345% |
| Biodesix, Inc. | -52.14 Million USD | 84.779% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -201.897% |
| Precipio, Inc. | -5.85 Million USD | -35.606% |
| iSpecimen Inc. | -11.09 Million USD | 28.492% |
| Natera, Inc. | -434.8 Million USD | 98.175% |
| Aspira Women's Health Inc. | -16.69 Million USD | 52.445% |
| Standard BioTools Inc. | -74.65 Million USD | 89.369% |
| 23andMe Holding Co. | -666.7 Million USD | 98.81% |
| Castle Biosciences, Inc. | -57.46 Million USD | 86.188% |
| Personalis, Inc. | -108.29 Million USD | 92.671% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | 91.03% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | 20.207% |
| OpGen, Inc. | -32.66 Million USD | 75.704% |
| T2 Biosystems, Inc. | -50.07 Million USD | 84.15% |
| Myriad Genetics, Inc. | -112 Million USD | 92.913% |
| ICON Public Limited Company | 612.33 Million USD | 101.296% |
| NeoGenomics, Inc. | -87.96 Million USD | 90.977% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -412.727% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 100.939% |
| RadNet, Inc. | 3.04 Million USD | 360.743% |
| MDxHealth SA | -43.1 Million USD | 81.585% |
| Psychemedics Corporation | -4.15 Million USD | -91.069% |
| Illumina, Inc. | -1.16 Billion USD | 99.316% |
| Check-Cap Ltd. | -17.56 Million USD | 54.821% |
| Twist Bioscience Corporation | -208.72 Million USD | 96.197% |
| DarioHealth Corp. | -59.42 Million USD | 86.644% |
| Fulgent Genetics, Inc. | -167.82 Million USD | 95.271% |
| Sera Prognostics, Inc. | -36.24 Million USD | 78.1% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | 21.105% |
| OPKO Health, Inc. | -188.86 Million USD | 95.797% |
| Medpace Holdings, Inc. | 282.81 Million USD | 102.806% |
| Neogen Corporation | -9.42 Million USD | 15.752% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | 21.855% |
| Prenetics Global Limited | -62.72 Million USD | 87.346% |
| Mainz Biomed B.V. | -26.29 Million USD | 69.816% |
| Trinity Biotech plc | -24.01 Million USD | 66.954% |
| Neuronetics, Inc. | -30.18 Million USD | 73.709% |
| Sotera Health Company | 51.37 Million USD | 115.449% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -0.0% |